ISSUP, in collaboration with Faces & Voices of Recovery, has launched a new Global Recovery Network webinar series to spotlight diverse perspectives on recovery. The first webinar featured Dr. Haner Hernández, a respected expert in the field and a person in long-term recovery. Dr. Hernández currently serves as a Senior Consultant to the Massachusetts Department of Public Health and plays a key role in advancing health equity, workforce development, and recovery support. His presentation provided an insightful and inclusive overview of multiple pathways to recovery, grounded in both...

Current evidence shows that medications are underused in the treatment of alcohol use disorder, including alcohol abuse and dependence.

Although many experts in addiction believe that patients with moderate or severe alcohol-related problems should be offered medication-assisted treatment (MAT) on a routine basis, considerable resistance to the use of MAT persists.

To clarify the situation, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) analysed the evidence on the effectiveness of available...

Abstract

Importance: The number of children with prenatal opioid exposure to medication for addiction treatment (MAT) with methadone and buprenorphine for maternal opioid use disorder is increasing, but the associations of this exposure with cognitive outcomes are not well understood.

Objective: To examine the strength and consistency of findings in the medical literature regarding the association of prenatal exposure to MAT with early childhood cognitive development, particularly when accounting for variables outside MAT exposure.

Data Sources: A search strategy obtained publications from...

Η επιτυχία της θεραπείας και της ανάρρωσης των ατόμων με διαταραχή χρήσης οπιοειδών (OUD) μπορεί να ποικίλει. Τις περισσότερες φορές, ένας συνδυασμός παραγόντων προσθέτει πολυπλοκότητα στην αξιολόγηση της αποτελεσματικότητας των υπηρεσιών και των παρεμβάσεων.

Παγκοσμίως, η υπερβολική δόση είναι η κύρια αιτία θανάτου που μπορεί να αποφευχθεί μεταξύ των ατόμων που κάνουν ενέσιμη χρήση ναρκωτικών. Ένας σημαντικός τομέας ανησυχίας για τη Διοίκηση Υπηρεσιών Κατάχρησης Ουσιών και Ψυχικής Υγείας (SAMHSA) είναι η προώθηση πολιτικών και πρακτικών για τη μείωση του κινδύνου υπερβολικής δόσης για άτομα...